Clinical Benefits of Photodynamic Therapy Using Talaporfin Sodium in Patients With Isocitrate Dehydrogenase-Wildtype Diagnosed Glioblastoma: A Retrospective Study of 100 Cases
PDT with talaporfin sodium provided effective local control with minimal adverse effects. The survival time of the patients treated with PDT was significantly longer than that of the patients who did not receive PDT. Therefore, a randomized controlled clinical trial on PDT is warranted.
Authors
- Takashi Sasayama (ORCID: https://orcid.org/0000-0002-5593-9045)
- Shunsuke Yamanishi (ORCID: https://orcid.org/0000-0002-8734-4169)
- Hiroaki Nagashima (ORCID: https://orcid.org/0000-0003-0685-7382)
- Hirofumi Iwahashi
- Yoshihiro Muragaki (ORCID: https://orcid.org/0000-0001-8336-5328)
- Kazuhiro Tanaka (ORCID: https://orcid.org/0000-0001-5862-560X)
- Yusuke Ikeuchi (ORCID: https://orcid.org/0009-0004-5364-7702)
- Shoji Sanada
- Yosuke Fujimoto
- Yuichi Fujita
Institutions
- Kobe University Hospital (JP)
- Kobe University (JP)
Publication Details
- Journal
- Neurosurgery
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1227/neu.0000000000003247
- Citations
- 3
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.26
Funders
- Ministry of Education, Culture, Sports, Science and Technology